I don't mean to sound like a broken record. But, the first three patients in the CHM CDH-17 trial were all dosed prior to 31st December 2024 (as per Quarterly released 31/01/2025).
So we should have received: Patient 2: 90 day results. Patient 3: 60 day results. We should also be close to Patient 4: 30 day results. Patient 4 is particularly important because that is the first in the dose escalation where they receive 150 million cells rather than the 50 million received by patients 1 - 3.
- Forums
- ASX - By Stock
- Ann: Quarterly Activities/Appendix 4C Cash Flow Report
CHM
chimeric therapeutics limited
Add to My Watchlist
0.00%
!
0.4¢

I don't mean to sound like a broken record. But, the first three...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $8.060M |
Open | High | Low | Value | Volume |
0.5¢ | 0.5¢ | 0.4¢ | $432 | 98K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
26 | 22188206 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 25892021 | 31 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
26 | 22188206 | 0.004 |
42 | 25331939 | 0.003 |
16 | 14000507 | 0.002 |
10 | 59600000 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 25892021 | 31 |
0.006 | 13747410 | 16 |
0.007 | 4700000 | 4 |
0.008 | 8542434 | 6 |
0.009 | 3727673 | 6 |
Last trade - 13.15pm 16/06/2025 (20 minute delay) ? |
Featured News
CHM (ASX) Chart |